Affymetrix Chairman and Founder to Retire from Board of Directors
January 30 2015 - 6:00AM
Business Wire
Affymetrix (NASDAQ:AFFX) today announced that Founder and
Chairman, Stephen Fodor, Ph.D., will retire from the company’s
Board of Directors effective January 30, 2015. He has served on the
Board since the Company’s inception, and has been Chairman since
1999. The Board of Directors elected Jami Nachtsheim as Chairwoman
of the Company’s Board of Directors, succeeding Dr. Fodor. Ms.
Nachtsheim has served as a director of the Company since 2010 and
the Company’s lead independent director since 2013.
Dr. Fodor founded the company in 1992, initially serving as its
Scientific Director. He was named the company’s President in 1993
and CEO from 1997 to 2008. Since 2011, Frank Witney, Ph.D., has
served as the company’s President and CEO and an Affymetrix Board
Director.
“Frank and the management team have done a terrific job
returning excitement and growth to the company, and I am confident
they will continue to be successful,” said Dr. Fodor. “This is the
right time to pursue my external activities. My interest,
involvement and enthusiasm for the life sciences industry will
continue.”
Frank Witney, President and CEO, said, “Steve’s insights,
leadership and vision have been core to the culture of Affymetrix.
Much of what we know about modern biology has been learned using
Affymetrix products, as evidenced by over 94,000 publications
referencing our technology. Steve built the foundation of
scientific innovation at the company, which we intend to carry
forward. We wish Steve all the best in his future endeavors.”
About Affymetrix
Affymetrix technologies enable multiplex and simultaneous
analysis of biological systems at the cell, protein, and gene
level, facilitating the rapid translation of bench-top research
into clinical and routine use for human health and wellness. The
Company provides leadership and support, partnering with customers
in pharmaceutical, diagnostic, and biotechnology companies, as well
as leading academic, government, and non-profit research institutes
in their quest to use biology for a better world. More than 2,300
microarray systems have been shipped around the world and more than
94,500 peer-reviewed papers have been published citing Affymetrix
technologies. Affymetrix is headquartered in Santa Clara,
California, and has manufacturing facilities in Cleveland, Ohio,
San Diego, Vienna, and Singapore. The Company has about 1,100
employees worldwide and maintains sales
and distribution operations across Europe, Asia, and
Latin America. For more information about Affymetrix, please
visit www.affymetrix.com.
AffymetrixMedia Contact:Mindy Lee-Olsen,
408-731-5523Vice President, Marketing
Servicesmindy_lee-olsen@affymetrix.comorInvestor
Contact:Doug Farrell, 408-731-5285Vice President, Investor
Relationsdoug_farrell@affymetrix.com
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jul 2023 to Jul 2024